August 22, 2026
  • August 22, 2026

Planful of US to invest $120m in expanding its Hyderabad R&D hub

By on September 11, 2024 0 19 Views

Aurobindo Pharma’s stepdown subsidiary, Eugia Steriles Private Ltd, has received its first product approval from the US FDA for Lidocaine Hydrochloride injection. The approval came after an inspection of their new injectables manufacturing facility in Andhra Pradesh. This achievement is pivotal for Aurobindo Pharma’s expansion plans.

Leave a comment

Your email address will not be published. Required fields are marked *